{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:27:43Z","timestamp":1793996863084,"version":"4.8.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.1001\/jamacardio.2021.1232","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:45:27Z","timestamp":1621439127000},"page":"918","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc Factors"],"prefix":"10.1001","volume":"6","author":[{"given":"Husam","family":"Abdel-Qadir","sequence":"first","affiliation":[{"name":"Division of Cardiology, Women's College Hospital, Toronto, Ontario, Canada"},{"name":"Division of Cardiology, Peter Munk Cardiac Centre, Department of Medicine University Health Network, Toronto, Ontario, Canada"},{"name":"ICES (formerly known as the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon M.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pang","sequence":"additional","affiliation":[{"name":"ICES (formerly known as the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[{"name":"ICES (formerly known as the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Jackevicius","sequence":"additional","affiliation":[{"name":"ICES (formerly known as the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"College of Pharmacy, Western University of Health Sciences, Pomona, California"},{"name":"Department of Pharmacy, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tu","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Research and Innovation, North York General Hospital Toronto, Ontario, Canada"},{"name":"Department of Family Medicine, North York General Hospital Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Toronto Western Hospital Family Health Team, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Cardiology, Department of Medicine, Unity Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[{"name":"ICES (formerly known as the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"hoi210028r1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9921","key":"hoi210028r2","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"hoi210028r3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"22","key":"hoi210028r4","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"hoi210028r5","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"38","key":"hoi210028r6","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"hoi210028r8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report.","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"11","key":"hoi210028r9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation.","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"issue":"1","key":"hoi210028r10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"hoi210028r11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003669","article-title":"Anticoagulation for nonvalvular atrial fibrillation: influence of epidemiologic trends and clinical practice patterns on risk stratification and net clinical benefit.","volume":"10","author":"Asinger","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"hoi210028r12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi210028r13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records.","volume":"33","author":"Schultz","year":"2013","journal-title":"Chronic Dis Inj Can"},{"issue":"2","key":"hoi210028r14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00005650-200502000-00012","article-title":"Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research.","volume":"43","author":"Lee","year":"2005","journal-title":"Med Care"},{"issue":"9","key":"hoi210028r15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jclinepi.2006.12.009","article-title":"ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions.","volume":"60","author":"Vermeulen","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"hoi210028r16","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1016\/S0828-282X(10)70412-8","article-title":"Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD).","volume":"26","author":"Tu","year":"2010","journal-title":"Can J Cardiol"},{"issue":"3","key":"hoi210028r17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"hoi210028r18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12913-018-3148-0","article-title":"Identifying diabetes cases from administrative data: a population-based validation study.","volume":"18","author":"Lipscombe","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"hoi210028r19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cjca.2013.07.676","article-title":"Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard.","volume":"29","author":"Tu","year":"2013","journal-title":"Can J Cardiol"},{"issue":"12","key":"hoi210028r20","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cjca.2016.06.006","article-title":"Identifying patients with atrial fibrillation in administrative data.","volume":"32","author":"Tu","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"hoi210028r21","first-page":"e18","article-title":"Accuracy of administrative databases in identifying patients with hypertension.","volume":"1","author":"Tu","year":"2007","journal-title":"Open Med"},{"issue":"9795","key":"hoi210028r22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(11)60990-2","article-title":"Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.","volume":"378","author":"Gershon","year":"2011","journal-title":"Lancet"},{"key":"hoi210028r23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2369-14-81","article-title":"Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes.","volume":"14","author":"Fleet","year":"2013","journal-title":"BMC Nephrol"},{"issue":"1","key":"hoi210028r24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JAD-160105","article-title":"Identification of physician-diagnosed Alzheimer\u2019s disease and related dementias in population-based administrative data: a validation study using family physicians\u2019 electronic medical records.","volume":"54","author":"Jaakkimainen","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"hoi210028r25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","article-title":"An application of capture-recapture methods to the estimation of completeness of cancer registration.","volume":"41","author":"Robles","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"10132","key":"hoi210028r26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study.","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"hoi210028r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201120","article-title":"Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study.","volume":"13","author":"Lapointe-Shaw","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"hoi210028r28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/CIRCOUTCOMES.114.001416","article-title":"The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.","volume":"8","author":"Tu","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"hoi210028r29","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1503\/cmaj.121218","article-title":"Rates of hemorrhage during warfarin therapy for atrial fibrillation.","volume":"185","author":"Gomes","year":"2013","journal-title":"CMAJ"},{"issue":"6","key":"hoi210028r31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1017\/cjn.2016.278","article-title":"Accuracy of administrative data for the coding of acute stroke and TIAs.","volume":"43","author":"Hall","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"hoi210028r32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fneur.2013.00069","article-title":"Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke.","volume":"4","author":"Sussman","year":"2013","journal-title":"Front Neurol"},{"issue":"8","key":"hoi210028r33","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study.","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"hoi210028r34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation.","volume":"71","author":"Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi210028r35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.annemergmed.2012.12.022","article-title":"Factors associated with 90-day death after emergency department discharge for atrial fibrillation.","volume":"61","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"6","key":"hoi210028r36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"issue":"5","key":"hoi210028r37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"issue":"17","key":"hoi210028r38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/sim.v39.17","article-title":"Matching with time-dependent treatments: a review and look forward.","volume":"39","author":"Thomas","year":"2020","journal-title":"Stat Med"},{"issue":"3","key":"hoi210028r39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","article-title":"Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests.","volume":"56","author":"Robins","year":"2000","journal-title":"Biometrics"},{"issue":"2","key":"hoi210028r40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0962280216628900","article-title":"Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.","volume":"27","author":"Willems","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"hoi210028r41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2009.03.012","article-title":"Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes.","volume":"63","author":"Austin","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"hoi210028r42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"hoi210028r43","doi-asserted-by":"publisher","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"14","key":"hoi210028r44","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.","volume":"65","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi210028r45","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/europace\/euv401","article-title":"Atrial fibrillation and risk of stroke: a nationwide cohort study.","volume":"18","author":"Christiansen","year":"2016","journal-title":"Europace"},{"issue":"3","key":"hoi210028r46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurheartj\/ehs314","article-title":"The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.","volume":"34","author":"Coppens","year":"2013","journal-title":"Eur Heart J"},{"issue":"10050","key":"hoi210028r47","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.","volume":"388","author":"Healey","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"hoi210028r48","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe.","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"issue":"12","key":"hoi210028r49","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cjca.2016.09.002","article-title":"At what age does stroke risk increase in patients with atrial fibrillation? does it depend on where you live?","volume":"32","author":"Healey","year":"2016","journal-title":"Can J Cardiol"},{"issue":"12","key":"hoi210028r50","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jacc.2015.07.026","article-title":"Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan.","volume":"66","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi210028r51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jacc.2016.05.044","article-title":"Refining stroke prediction in atrial fibrillation patients by addition of African-American ethnicity to CHA2DS2-VASc Score.","volume":"68","author":"Kabra","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi210028r52","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004580","article-title":"Importance of considering competing risks in time-to-event analyses: application to stroke risk in a retrospective cohort study of elderly patients with atrial fibrillation.","volume":"11","author":"Abdel-Qadir","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"hoi210028r53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","article-title":"Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.","volume":"56","author":"Marinigh","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi210028r54","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"hoi210028r55","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"hoi210028r30"},{"key":"hoi210028r7","unstructured":"National Institute for Health and Clinical Excellence. Atrial fibrillation: management, clinical guideline [CG 180]. Updated August 1, 2014. Accessed October 25, 2019. https:\/\/www.nice.org.uk\/guidance\/cg180"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2780127\/jamacardiology_abdelqadir_2021_oi_210028_1628256757.04941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:07:41Z","timestamp":1628539661000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2780127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.1232","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}